L'Università degli Studi di Torino, o semplicemente Università di Torino, è un'università statale italiana, fondata a Torino nel XV secolo.

During the past decade, University of Torino conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 14 clinical trials were completed, i.e. on average, 87.5% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 3 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Torino" #1 sponsor was "Fred Hutchinson Cancer Center" with 16 trials, followed by "European Organisation for Research and Treatment of Cancer - EORTC" with 8 trials sponsored, "University of Turin, Italy" with 3 trials sponsored, "European Institute of Oncology" with 2 trials sponsored and "Giovanni Di Perri" with 2 trials sponsored. Other sponsors include 11 different institutions and companies that sponsored additional 20 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Torino" #1 collaborator was "National Cancer Institute (NCI)" with 16 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 6 trials as a collaborator, "University of Turin, Italy" with 3 trials as a collaborator, "AZ Sint-Jan AV" with 1 trials as a collaborator and "Assistance Publique - Hôpitaux de Paris" with 1 trials as a collaborator. Other collaborators include 25 different institutions and companies that were collaborators in the rest 35 trials.

According to Clinical.Site data, the most researched conditions in "University of Torino" are "Refractory Chronic Lymphocytic Leukemia" (11 trials), "Recurrent Small Lymphocytic Lymphoma" (9 trials), "Refractory Multiple Myeloma" (9 trials), "Recurrent Adult Acute Lymphoblastic Leukemia" (8 trials) and "Recurrent Adult Acute Myeloid Leukemia" (8 trials). Many other conditions were trialed in "University of Torino" in a lesser frequency.

Most popular intervention types in "University of Torino" are "Drug" (32 trials), "Procedure" (24 trials), "Radiation" (16 trials), "Biological" (13 trials) and "Other" (12 trials). Other intervention types were less common.

The name of intervention was led by "mycophenolate mofetil" (9 trials), "peripheral blood stem cell transplantation" (9 trials), "total-body irradiation" (9 trials), "cyclosporine" (8 trials) and "fludarabine phosphate" (7 trials). Other intervention names were less common.

The vast majority of trials in "University of Torino" are 42 trials for "All" genders, 4 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "University of Torino". undefined are not yet recruiting, 4 are recruiting, 1 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 25 completed trials in University of Torino, undefined suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in University of Torino, 8 "Phase 1" clinical trials were conducted, 19 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 4 trials that are defined as “Not Applicable".

University of Torino has several departments that took part in Clinical trials: "Dip. di Scienze Cliniche e Biologiche - Ospedale S. Luigi Gonzaga-Medicina Interna 2" - 8 trials, "CIR Dental School" - 5 trials, "Universita degli Studi di Torino - Centro Regionale Esperto Per La Sclerosi Laterale Amiotrofica (CRESLA)" - 5 trials, "Dip. di Scienze Cliniche e Biologiche - Ospedale S. Luigi Gonzaga" - 4 trials, "Department of Biological and Clinical Science - University of Turin" - 3 trials, "Dip. di Scienze Cliniche e Biologiche - Ospedale S. Luigi Gonzaga-Medicina Interna 2 Prof. Giuseppe Saglio" - 2 trials, "AOU San Luigi- Department of Oncology" - 2 trials